Author

Yu-Ping Yang

Gilead Sciences (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:organoid / primary culture· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Aaron C. Trotman-GrantiD· 1 shared Ana Jimena Pavlovitch-BedzykiD· 1 shared Anne Lynn S. ChangiD· 1 shared Anthony Francois· 1 shared Arya KhokhariD· 1 shared Asmita BhattacharyaiD· 1 shared Calvin Jay KuoiD· 1 shared Cara Coleen RadaiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aaron C. Trotman-GrantORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Organoid modeling of tumor-associated macrophages reveals phagocytosis checkpoint blockade-induced conversion to an immunosuppressive SPP1+ phenotype

Michitaka Nakano, Lyong Heo, Yu-Ping Yang, Lorena P. Munoz, Yihua Liu, Lei Zhao, Juhyung Park, Eirini Tsekitsidou, Anthony Francois, Jie Liu, Aaron C. Trotman-Grant, Maria Fernanda Henao Echeverri, Cara Coleen Rada, Edward Tran, Arya Khokhar, , Calvin Jay Kuo

The paper uses patient-derived organoids to study TAM responses to CD47 checkpoint blockade, revealing a conversion to an immunosuppressive SPP1+ phenotype in clear cell renal cell carcinoma.

bioRxiv · May 9, 2026 · PreprintCancer Biology